Portal de Periódicos da CAPES

A maternally inherited 16p13.11‐p12.3 duplication concomitant with a de novo SOX5 deletion in a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features

2015; Wiley; Volume: 167; Issue: 6 Linguagem: Inglês

10.1002/ajmg.a.36909

1552-4833

Inés Quintela, Francisco Barros, Ramón Manuel Lago‐Lestón, Manuel Castro‐Gago, Ángel Carracedo, Jesús Manuel Eirís Puñal,

Congenital heart defects research

We detail here the clinical description and the family genetic study of a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features and a combination of two rare genetic variants: a maternally inherited 16p13.11‐p12.3 duplication and a de novo 12p12.1 deletion affecting SOX5 . The 16p13.11 microduplication has been implicated in several neurodevelopmental and behavioral disorders and is characterized by variable expressivity and incomplete penetrance. The causes of this variation in phenotypic expression are not fully clear, representing a challenge in genetic diagnosis and counseling. However, several authors have proposed the two‐hit model as one of the underlying mechanisms for this phenotypic heterogeneity. Our data could also support this two‐hit model in which the 16p13.11‐p12.3 duplication might contribute to the phenotype, not only as a single event but also in association with the SOX5 deletion. The SOX5 gene plays important roles in various developmental processes and has been associated with several neurodevelopmental disorders, mainly intellectual disability, developmental delay and language and/or speech delay as well as with behavior problems and dysmorphic features. However, many of the physical features and behavioral manifestations as well as language deficiencies present in our patient are consistent with those previously reported for SOX5 deletions. Patients carrying multiple genomic variants, as the one presented here, illustrate the difficulty in analyzing genotypes when the contribution of each variant results in overlapping phenotypes and/or, alternatively, in the modification of the clinical manifestations defined by the coexisting variant. © 2015 Wiley Periodicals, Inc.